Noel T Brewer1,2, Megan E Hall3, Teri L Malo2, Melissa B Gilkey4, Beth Quinn5, Christine Lathren3. 1. Department of Health Behavior, Gillings School of Global Public Health, and ntb@unc.edu. 2. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. 3. Department of Health Behavior, Gillings School of Global Public Health, and. 4. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and. 5. North Carolina Immunization Branch, Raleigh, North Carolina.
Abstract
OBJECTIVE: Improving provider recommendations is critical to addressing low human papillomavirus (HPV) vaccination coverage. Thus, we sought to determine the effectiveness of training providers to improve their recommendations using either presumptive "announcements" or participatory "conversations." METHODS: In 2015, we conducted a parallel-group randomized clinical trial with 30 pediatric and family medicine clinics in central North Carolina. We randomized clinics to receive no training (control), announcement training, or conversation training. Announcements are brief statements that assume parents are ready to vaccinate, whereas conversations engage parents in open-ended discussions. A physician led the 1-hour, in-clinic training. The North Carolina Immunization Registry provided data on the primary trial outcome: 6-month coverage change in HPV vaccine initiation (≥1 dose) for adolescents aged 11 or 12 years. RESULTS: The immunization registry attributed 17 173 adolescents aged 11 or 12 to the 29 clinics still open at 6-months posttraining. Six-month increases in HPV vaccination coverage were larger for patients in clinics that received announcement training versus those in control clinics (5.4% difference, 95% confidence interval: 1.1%-9.7%). Stratified analyses showed increases for both girls (4.6% difference) and boys (6.2% difference). Patients in clinics receiving conversation training did not differ from those in control clinics with respect to changes in HPV vaccination coverage. Neither training was effective for changing coverage for other vaccination outcomes or for adolescents aged 13 through 17 (n = 37 796). CONCLUSIONS: Training providers to use announcements resulted in a clinically meaningful increase in HPV vaccine initiation among young adolescents.
RCT Entities:
OBJECTIVE: Improving provider recommendations is critical to addressing low human papillomavirus (HPV) vaccination coverage. Thus, we sought to determine the effectiveness of training providers to improve their recommendations using either presumptive "announcements" or participatory "conversations." METHODS: In 2015, we conducted a parallel-group randomized clinical trial with 30 pediatric and family medicine clinics in central North Carolina. We randomized clinics to receive no training (control), announcement training, or conversation training. Announcements are brief statements that assume parents are ready to vaccinate, whereas conversations engage parents in open-ended discussions. A physician led the 1-hour, in-clinic training. The North Carolina Immunization Registry provided data on the primary trial outcome: 6-month coverage change in HPV vaccine initiation (≥1 dose) for adolescents aged 11 or 12 years. RESULTS: The immunization registry attributed 17 173 adolescents aged 11 or 12 to the 29 clinics still open at 6-months posttraining. Six-month increases in HPV vaccination coverage were larger for patients in clinics that received announcement training versus those in control clinics (5.4% difference, 95% confidence interval: 1.1%-9.7%). Stratified analyses showed increases for both girls (4.6% difference) and boys (6.2% difference). Patients in clinics receiving conversation training did not differ from those in control clinics with respect to changes in HPV vaccination coverage. Neither training was effective for changing coverage for other vaccination outcomes or for adolescents aged 13 through 17 (n = 37 796). CONCLUSIONS: Training providers to use announcements resulted in a clinically meaningful increase in HPV vaccine initiation among young adolescents.
Authors: Mandy A Allison; Laura P Hurley; Lauri Markowitz; Lori A Crane; Michaela Brtnikova; Brenda L Beaty; Megan Snow; Janine Cory; Shannon Stokley; Jill Roark; Allison Kempe Journal: Pediatrics Date: 2016-01-04 Impact factor: 7.124
Authors: Noel T Brewer; Sami L Gottlieb; Paul L Reiter; Annie-Laurie McRee; Nicole Liddon; Lauri Markowitz; Jennifer S Smith Journal: Sex Transm Dis Date: 2011-03 Impact factor: 2.830
Authors: Douglas J Opel; Rita Mangione-Smith; Jeffrey D Robinson; John Heritage; Victoria DeVere; Halle S Salas; Chuan Zhou; James A Taylor Journal: Am J Public Health Date: 2015-03-19 Impact factor: 9.308
Authors: Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-22 Impact factor: 4.254
Authors: Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer Journal: Vaccine Date: 2016-01-24 Impact factor: 3.641
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: A T Chamberlain; R J Limaye; S T O'Leary; P M Frew; S E Brewer; C I Spina; M K Ellingson; M Z Dudley; W A Orenstein; M A Donnelly; L E Riley; K A Ault; D A Salmon; S B Omer Journal: Vaccine Date: 2019-04-05 Impact factor: 3.641
Authors: Emily B Walling; Sherry Dodd; Neil Bobenhouse; Evelyn Cohen Reis; Randy Sterkel; Jane Garbutt Journal: Am J Prev Med Date: 2019-01 Impact factor: 5.043
Authors: Suellen Hopfer; Margaret E Wright; Harry Pellman; Richard Wasserman; Alexander G Fiks Journal: Hum Vaccin Immunother Date: 2019-01-30 Impact factor: 3.452
Authors: Lila J Finney Rutten; Jennifer L St Sauver; Timothy J Beebe; Patrick M Wilson; Debra J Jacobson; Chun Fan; Carmen Radecki Breitkopf; Susan T Vadaparampil; Kathy L MacLaughlin; Robert M Jacobson Journal: Vaccine Date: 2017-09-27 Impact factor: 3.641
Authors: Melissa B Gilkey; Divya Mohan; Ellen M Janssen; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges Journal: Hum Vaccin Immunother Date: 2019-05-07 Impact factor: 3.452
Authors: Jenna E Reno; Jacob Thomas; Jennifer Pyrzanowski; Steven Lockhart; Sean T O'Leary; Elizabeth J Campagna; Amanda F Dempsey Journal: Hum Vaccin Immunother Date: 2019-01-16 Impact factor: 3.452
Authors: Kimberly A Fisher; Andy S L Tan; Daniel D Matlock; Barry Saver; Kathleen M Mazor; Arwen H Pieterse Journal: Patient Educ Couns Date: 2018-08-06